Search Results - Yu. G. Shvarts
- Showing 1 - 17 results of 17
-
1
Hypertension, cardiovascular risk and exercise in middle-aged and elderly people: a narrative review by M. O. Vyalova, Yu. G. Shvarts
Published 2023-12-01Hypertension (HTN) is widespread among middle-aged and elderly people, including those doing sports. For the first time in 2020, the European Society of Cardiology guidelines on sports cardiology and exercise in patients with cardiovascular disease included adult and elderly patients in a separate g...
Get full text
Article -
2
Polymorphism of ACE, AGT, AGTR1 genes as genetic predictors of hypertension by A. Yu. Elkina, N. S. Akimova, Yu. G. Shvarts
Published 2021-04-01The genetic architecture of blood pressure (BP) includes more than 30 genes, the polymorphic variants of which cause phenotypic heterogeneity of BP. Given that a human genetic information is largely stable from birth, it can act as an early predictor of hypertension (HTN). Identification of polymorp...
Get full text
Article -
3
Symptomatic hypotensive episodes in patients with hypertension. Relationship with blood pressure self-monitoring parameters by S. A. Ermasova, I. M. Sokolov, Yu. G. Shvarts
Published 2021-07-01Aim. To study the relationship between symptomatic hypotensive episodes (SHEs) and parameters of self-monitoring of blood pressure (SMPB) in patients with hypertension (HTN).Material and methods. A total of 77 patients from 40 to 76 years old with HTN were examined. To identify SHEs, an original que...
Get full text
Article -
4
Cardiovascular risk factors and blood pressure response to various types of exercise in veteran athletes by A. S. Shmoilova, M. O. Vyalova, Yu. G. Shvarts
Published 2021-05-01Aim. To study the main cardiovascular risk (CVR) factors and assess the blood pressure (BP) response to various types of exercise in veteran athletes.Material and methods. In order to identify the main CVR factors, 234 competitive athletes and 29 persons practicing physical training were interviewed...
Get full text
Article -
5
Combination of coronary heart disease, chronic heart failure, and anaemic syndrome: clinical features and prognostic impact of anaemia treatment by T. Yu. Kalyuta, Yu. G. Shvarts, I. M. Sokolov
Published 2013-04-01Practitioners are often faced with a combination of coronary heart disease (CHD), chronic heart failure (CHF), and anaemic syndrome. These patients are typically characterised by a worse prognosis of acute and chronic CHD, as well as by a rapid progression of CHF and chronic renal failure (CKF).This...
Get full text
Article -
6
THE ATTITUDE TOWARDS TREATMENT OF CARDIOVASCULAR DISEASES: A SURVEY OF PATIENTS OF STATE OUTPATIENT CLINICS AND PRIVATE MEDICAL CENTERS by O. N. Semenova, E. A. Naumova, Yu. G. Shvarts
Published 2015-09-01Aim. To study the differences in views on treatment among patients with cardiovascular diseases in state and private outpatient clinics, as well as the motivation for choosing one of these outpatient clinics.Material and methods. Anonymous and voluntary survey of cardiology patients (n=90) in 2 stat...
Get full text
Article -
7
Hypertensive disease after moderate coronavirus infection. The results of six-month follow-up by D. О. Fedoseeva, I. M. Sokolov, Yu. G. Shvarts
Published 2023-07-01Aim. This study aims to assess the clinical specificity of course of hypertensive disease (HD) during the first 6 months after new coronavirus infection (COVID-19) and to investigate prognostic significance of laboratory and instrumental parameters for organ dysfunctions in acute period of COVID-19...
Get full text
Article -
8
ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT by E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
Published 2015-09-01Data on the problem of thromboembolic complications in non-valvular atrial fibrillation are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties in drug choice and dosage adjustment are also discussed.
Get full text
Article -
9
INTERRELATION OF ATHEROSCLEROSIS RISK FACTORS AND CENTRAL NERVOUS SYSTEM CONDITION IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN by N. S. Akimova, T. V. Martynovich, D. G. Persashvili, Yu. G. Shvarts
Published 2014-08-01Aim. Chronic heart failure is one of the factors of the development and progression of cognitive disorders. To study the relationships between risk factors of atherosclerosis and condition of the central nervous system in patients with chronic heart failure of ischemic etiology.Material and methods....
Get full text
Article -
10
GENE POLYMORPHISM IN ASSOCIATION WITH ATHEROSCLEROSIS DEVELOPMENT AND COGNITION DISORDERS IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE by T. V. Martynovich, N. S. Akimova, E. A. Fedotov, Yu. G. Shvarts
Published 2015-02-01Aim. To study the interrelation of polymorphic gene variants playing role in atherosclerosis development, with cognition disorders, central nervous system condition and chronic heart failure (CHF) course specifics in patients with ischemic heart disease. Material and methods. 40 patients with CHF I-...
Get full text
Article -
11
The problem of cross risk of arterial hypertension progression, obstructive sleep apnea syndrome and COVID-19 by К. A. Popov, Yu. V. Bulaeva, S. A. Ermasova, Yu. G. Shvarts
Published 2023-07-01This review considers the risk factors for arterial hypertension (AH) progression, obstructive sleep apnea syndrome (OSAS) and novel coronavirus infection (COVID-19) as potential variables for the prognostic models of estimating the probability of destabilization of the mentioned conditions. The mos...
Get full text
Article -
12
ARTERIAL HYPERTENSION AT SPORT ACTIVITIES IN MIDDLE AGE AND ELDERLY SPORTSMEN by M. O. Tsareva, E. N. Korsunova, A. S. Shmoylova, Yu. G. Shvarts
Published 2018-02-01Aim. To analyze the changes of systemic arterial pressure (BP) before and after sport load, incl. the diagnosis of arterial hypertension (AH) and antihypertensive treatment, in veteran sportsmen.Material and methods. Questionnaires were applied for the main cardiovascular risk factors assessment, an...
Get full text
Article -
13
Risk of sudden cardiac death in strength training by A. D. Smirnova, A. V. Novitsky, A. S. Shmoilova, Yu. G. Shvarts
Published 2022-02-01Physical activity is a generally accepted means of primary and secondary prevention of cardiovascular diseases, but in some cases, it can be a risk factor for cardiovascular events, including sudden cardiac death (SCD). Most studies analyze the relationship of cardiovascular events with the volume a...
Get full text
Article -
14
THE GENES ASSOCIATED WITH LIPID METABOLISM DISORDERS AND WITH BLOOD PRESSURE REGULATION, AND PSYCHOVEGETATIVE CHANGES IN THE YOUNG ALMOST HEALTHY PERSONS by Yu. G. Shvarts, A. Yu. Elkina, N. S. Akimova, T. V. Martynovich, E. A. Fedotov
Published 2016-12-01Aim. To assess the relation of polymorphism of the genes APOC3, PON1, AGT, AGTR1 and psychovegetative disorders in young, relatively healthy persons.Material and methods. Totally, 75 healthy volunteers included, white race, aged 20-25 y.o. Psychovegetative status was assessed with tests for panic...
Get full text
Article -
15
PROGNOSTIC SIGNIFICANCE OF THE VNTR POLYMORPHISM INTRON 4 OF THE GENE OF NITRIC OXIDE ENDOTHELIAL SYNTHASE IN CHRONIC HEART FAILURE PATIENTS by E. A. Polunina, Yu. G. Shvarts, I. V. Sevostianova, О. S. Polunina, L. P. Voronina
Published 2018-02-01Aim. To analyze the prevalence of VNTR-polymorphism intron 4 (4b/4b and 4a/4b) carriage of the gene of endothelial nitric oxide synthase (eNOS) in chronic heart failure patients (CHF) of ischemic origin according to ejection fraction of the left ventricle (LVEF) and the disease stage.Material and me...
Get full text
Article -
16
Technologically-Treated Polyclonal Affinity-Purified Antibodies to the Tumor Necrosis Factor-α, Brain Specific S-100 Protein and Histamine in Treatment of Functional Dyspepsia: Res... by Yu. O. Shulpekova, I. V. Maev, V. B. Grinevich, I. B. Khlynov, Yu. G. Shvarts, V. T. Ivashkin
Published 2022-09-01The aim of the study was to evaluate the efficacy and safety of Kolofort® (a complex medicine containing technologically processed forms of antibodies to S-100 protein, tumor necrosis factor-α and histamine) in the management of functional dyspepsia (FD) in outpatient clinical practice.Methods: Outp...
Get full text
Article -
17
Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III by E. V. Akatova, Yu. S. Bakhareva, O. V. Bugrova, I. B. Vinogradova, E. V. Gerasimova, Yu. E. Drevina, O. B. Ershova, E. V. Zonova, Yu. I. Ivanova, E. P. Ilivanova, M. M. Kostik, D. G. Krechikova, D. A. Kusevich, A. L. Maslyansky, A. D. Meshkov, N. S. Mosesova, K. A. Nagornova, D. V. Nosovich, S. A. Polyakova, T. A. Popova, E. A. Smolyarchuk, V. N. Sorotskaya, Yu. G. Shvarts, L. N. Shilova, M. S. Shostak, I. Yu. Yunonin, N. E. Akhtyamova-Givirovskaya, R. A. Khamitov, O. A. Markova, E. I. Zagoruiko, E. V. Zuev
Published 2024-12-01The article discusses the results of a comparative phase III clinical trial of the efficacy and safety of the biosimilar Complarate (CPR; JSC Generium, Russia) and the reference drug Actemra (ACT; F. Hoffmann-La Roche Ltd., Switzerland) to assess their equivalence in patients with rheumatoid arthrit...
Get full text
Article